Madrigal Pharmaceuticals, Inc. (MDGL)
511.97
-4.77
(-0.92%)
USD |
NASDAQ |
Aug 24, 16:00
511.84
-0.13
(-0.03%)
After-Hours: 20:00
Madrigal Pharmaceuticals Max Drawdown (5Y) : 82.20% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 82.20% |
| June 30, 2026 | 82.20% |
| May 31, 2026 | 82.20% |
| April 30, 2026 | 82.20% |
| March 31, 2026 | 82.20% |
| February 28, 2026 | 82.20% |
| January 31, 2026 | 82.20% |
| December 31, 2025 | 82.20% |
| November 30, 2025 | 82.20% |
| October 31, 2025 | 82.20% |
| September 30, 2025 | 82.20% |
| August 31, 2025 | 82.20% |
| July 31, 2025 | 82.20% |
| June 30, 2025 | 82.20% |
| May 31, 2025 | 82.20% |
| April 30, 2025 | 82.20% |
| March 31, 2025 | 82.20% |
| February 28, 2025 | 82.20% |
| January 31, 2025 | 82.20% |
| December 31, 2024 | 82.20% |
| November 30, 2024 | 82.20% |
| October 31, 2024 | 82.20% |
| September 30, 2024 | 82.20% |
| August 31, 2024 | 82.20% |
| July 31, 2024 | 82.20% |
| Date | Value |
|---|---|
| June 30, 2024 | 82.20% |
| May 31, 2024 | 82.20% |
| April 30, 2024 | 82.20% |
| March 31, 2024 | 82.20% |
| February 29, 2024 | 82.20% |
| January 31, 2024 | 82.20% |
| December 31, 2023 | 82.20% |
| November 30, 2023 | 82.20% |
| October 31, 2023 | 82.20% |
| September 30, 2023 | 82.20% |
| August 31, 2023 | 82.20% |
| July 31, 2023 | 82.20% |
| June 30, 2023 | 82.20% |
| May 31, 2023 | 82.20% |
| April 30, 2023 | 82.20% |
| March 31, 2023 | 82.20% |
| February 28, 2023 | 82.20% |
| January 31, 2023 | 82.20% |
| December 31, 2022 | 82.20% |
| November 30, 2022 | 88.70% |
| October 31, 2022 | 90.40% |
| September 30, 2022 | 90.40% |
| August 31, 2022 | 95.82% |
| July 31, 2022 | 96.22% |
| June 30, 2022 | 96.30% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Insmed, Inc. | 63.30% |
| PTC Therapeutics, Inc. | 73.78% |
| Protagonist Therapeutics, Inc. | 85.79% |
| Exelixis, Inc. | 53.09% |
| Karyopharm Therapeutics, Inc. | 99.11% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 45.47 |
| Beta (5Y) | -1.006 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 149.2% |
| Historical Sharpe Ratio (5Y) | 0.2427 |
| Historical Sortino (5Y) | 1.442 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 20.60% |